Neuphoria Therapeutics (NEUP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.30, -0.30% vs the prior close of $3.31.
- Volume 73.05K shares, 2.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NEUP dips 0.3% to $3.30 on 2.5x normal volume. Closed at $3.30, -0.30% vs the prior close of $3.31. Day range $3.24–$3.41, opened at $3.35.
NEUP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NEUP dips 0.3% to $3.30 on 2.5x normal volume
- Closed at $3.30, -0.30% vs the prior close of $3.31. Day range $3.24–$3.41, opened at $3.35.
- Volume was 73.05K shares, 2.5x its 50-day average of 29.30K — unusually heavy trading.
- Price is -10.4% vs its 50-day average ($3.68) and -21.4% vs its 200-day average ($4.20).
- 52-week range $3.19–$17.19; today's close sits at 1% of that range, 80.8% below the 52-week high.
Oct 15, 2026 — NEUP rises 2.2% to $3.31
- Closed at $3.31, +2.16% vs the prior close of $3.24. Day range $3.25–$3.42, opened at $3.25.
- Volume was 18.70K shares, 0.6x its 50-day average of 29.74K.
- Price is -10.4% vs its 50-day average ($3.69) and -21.2% vs its 200-day average ($4.20).
- 52-week range $3.19–$17.90; today's close sits at 1% of that range, 81.5% below the 52-week high.
Oct 14, 2026 — NEUP slides 4.4% to $3.24, a 52-week low
- Closed at $3.24, -4.42% vs the prior close of $3.39. Day range $3.24–$3.37, opened at $3.32.
- Volume was 44.10K shares, 1.5x its 50-day average of 29.70K.
- Price is -12.6% vs its 50-day average ($3.71) and -22.9% vs its 200-day average ($4.20).
- 52-week range $3.19–$17.90; today's close sits at 0% of that range, 81.9% below the 52-week high.
Oct 13, 2026 — NEUP rises 2.1% to $3.39
- Closed at $3.39, +2.11% vs the prior close of $3.32. Day range $3.32–$3.49, opened at $3.49.
- Volume was 26.60K shares, 0.9x its 50-day average of 30.33K.
- Price is -8.9% vs its 50-day average ($3.72) and -19.4% vs its 200-day average ($4.20).
- 52-week range $3.19–$18.39; today's close sits at 1% of that range, 81.6% below the 52-week high.
Oct 12, 2026 — NEUP dips 1.2% to $3.32, a 1-month low
- Closed at $3.32, -1.19% vs the prior close of $3.36. Day range $3.32–$3.38, opened at $3.32.
- Volume was 10.00K shares, 0.3x its 50-day average of 30.87K — lighter than usual.
- Price is -11.0% vs its 50-day average ($3.73) and -21.1% vs its 200-day average ($4.21).
- 52-week range $3.19–$19.21; today's close sits at 1% of that range, 82.7% below the 52-week high.
Oct 9, 2026 — NEUP ends flat (+0.3%) to $3.36
- Closed at $3.36, +0.30% vs the prior close of $3.35. Day range $3.32–$3.41, opened at $3.33.
- Volume was 2.50K shares, 0.1x its 50-day average of 32.24K — lighter than usual.
- Price is -10.2% vs its 50-day average ($3.74) and -20.1% vs its 200-day average ($4.21).
- 52-week range $3.19–$19.21; today's close sits at 1% of that range, 82.5% below the 52-week high.
Oct 8, 2026 — NEUP dips 2.0% to $3.35, a 1-month low, 12 down days in a row
- Closed at $3.35, -2.05% vs the prior close of $3.42. Day range $3.34–$3.42, opened at $3.40.
- Volume was 16.50K shares, 0.5x its 50-day average of 33.54K — lighter than usual.
- Price is -10.7% vs its 50-day average ($3.75) and -20.4% vs its 200-day average ($4.21).
- 52-week range $3.19–$19.56; today's close sits at 1% of that range, 82.9% below the 52-week high.
- That makes 12 straight losses.
Oct 7, 2026 — NEUP dips 0.9% to $3.42, a 1-month low, 11 down days in a row
- Closed at $3.42, -0.87% vs the prior close of $3.45. Day range $3.40–$3.45, opened at $3.40.
- Volume was 4.50K shares, 0.1x its 50-day average of 35.39K — lighter than usual.
- Price is -9.1% vs its 50-day average ($3.76) and -18.8% vs its 200-day average ($4.21).
- 52-week range $3.19–$21.40; today's close sits at 1% of that range, 84.0% below the 52-week high.
- That makes 11 straight losses.
Oct 6, 2026 — NEUP ends flat (+0.0%) to $3.45, 10 down days in a row
- Closed at $3.45, +0.00% vs the prior close of $3.45. Day range $3.43–$3.50, opened at $3.45.
- Volume was 16.50K shares, 0.4x its 50-day average of 39.17K — lighter than usual.
- Price is -8.5% vs its 50-day average ($3.77) and -18.2% vs its 200-day average ($4.22).
- 52-week range $3.19–$21.40; today's close sits at 1% of that range, 83.9% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 — NEUP dips 0.6% to $3.45, a 1-month low, 9 down days in a row
- Closed at $3.45, -0.58% vs the prior close of $3.47. Day range $3.43–$3.50, opened at $3.45.
- Volume was 15.50K shares, 0.3x its 50-day average of 46.71K — lighter than usual.
- Price is -8.7% vs its 50-day average ($3.78) and -18.2% vs its 200-day average ($4.22).
- 52-week range $3.19–$21.40; today's close sits at 1% of that range, 83.9% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — NEUP dips 1.1% to $3.47, a 1-month low, 8 down days in a row
- Closed at $3.47, -1.14% vs the prior close of $3.51. Day range $3.45–$3.59, opened at $3.51.
- Volume was 12.60K shares, 0.1x its 50-day average of 198.93K — lighter than usual.
- Price is -8.2% vs its 50-day average ($3.78) and -17.8% vs its 200-day average ($4.22).
- 52-week range $3.19–$21.40; today's close sits at 2% of that range, 83.8% below the 52-week high.
- That makes 8 straight losses.
NEUP latest news & SEC filings
Every SEC filing by or about NEUP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 18, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 18, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 18, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 18, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $1.17M (prior year $15.65M) (-92.5% vs Jun 30, 2025)
- Net income: -$13.45M (prior year -$369.63K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$3.06 (prior year -$0.23) (loss widened vs Jun 30, 2025)
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 24, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.01 — Change in control of the company.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade NEUP
- Last results release: May 20, 2025 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 1.11% (largest 4.4%).
- Liquidity: about 16.50K shares (≈$54.44K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.30 vs a range of $3.19–$17.19 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:12 on Dec 24, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Capital Management Lp Lynx1 bought 639,110 shares on Oct 21, 2025.
- Latest filings: 10-K Sep 18, 2026; 8-K Jul 24, 2026; 8-K May 26, 2026.
- Share count: 5.41M shares outstanding (Sep 17, 2026), +129.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NEUP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.35 | 3.41 | 3.24 | 3.30 | 73.05K |
| Oct 15, 2026 | 3.25 | 3.42 | 3.25 | 3.31 | 18.70K |
| Oct 14, 2026 | 3.32 | 3.37 | 3.24 | 3.24 | 44.10K |
| Oct 13, 2026 | 3.49 | 3.49 | 3.32 | 3.39 | 26.60K |
| Oct 12, 2026 | 3.32 | 3.38 | 3.32 | 3.32 | 10.00K |
| Oct 9, 2026 | 3.33 | 3.41 | 3.32 | 3.36 | 2.50K |
| Oct 8, 2026 | 3.40 | 3.42 | 3.34 | 3.35 | 16.50K |
| Oct 7, 2026 | 3.40 | 3.45 | 3.40 | 3.42 | 4.50K |
| Oct 6, 2026 | 3.45 | 3.50 | 3.43 | 3.45 | 16.50K |
| Oct 5, 2026 | 3.45 | 3.50 | 3.43 | 3.45 | 15.50K |
| Oct 2, 2026 | 3.51 | 3.59 | 3.45 | 3.47 | 12.60K |
| Oct 1, 2026 | 3.53 | 3.54 | 3.50 | 3.51 | 14.30K |
| Sep 30, 2026 | 3.60 | 3.62 | 3.53 | 3.56 | 10.40K |
| Sep 29, 2026 | 3.64 | 3.65 | 3.57 | 3.57 | 15.00K |
| Sep 28, 2026 | 3.67 | 3.69 | 3.65 | 3.65 | 2.90K |
| Sep 25, 2026 | 3.67 | 3.67 | 3.65 | 3.65 | 1.30K |
| Sep 24, 2026 | 3.67 | 3.70 | 3.65 | 3.65 | 5.40K |
| Sep 23, 2026 | 3.69 | 3.76 | 3.66 | 3.68 | 15.50K |
| Sep 22, 2026 | 3.73 | 3.77 | 3.71 | 3.73 | 6.70K |
| Sep 21, 2026 | 3.69 | 3.79 | 3.68 | 3.71 | 17.90K |
About Neuphoria Therapeutics
Neuphoria Therapeutics (NEUP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BURLINGTON, MA. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1191070.
NEUP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter Miles Winston Davies | Director | Jan 21, 2026 |
| Alan Fisher | Director | Jan 21, 2026 |
| Jane Ryan | Director | Jan 21, 2026 |
| David Ian Wilson | Director | Jan 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 21, 2025 | Capital Management Lp Lynx1 | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Capital Management Lp Lynx1 | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Weston Nichols | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Weston Nichols | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Capital Management Lp Lynx1 | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Capital Management Lp Lynx1 | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Weston Nichols | Buy | 639,110 | $5.14 |
| Oct 21, 2025 | Weston Nichols | Buy | 639,110 | $5.14 |
NEUP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-13.45M | -3.06 | $-12.35M |
| Jun 30, 2025 | $15.65M | $-369.63K | -0.23 | $77.23K |
| Jun 30, 2024 | — | $-15.49M | -18.62 | $-14.68M |
| Jun 30, 2023 | — | $-21.38M | -0.02 | $-14.64M |
Latest balance sheet: total assets $28.71M, total liabilities $4.11M, cash $19.87M (as of Jun 30, 2026).
NEUP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 20, 2025 | 8-K Item 2.02 (results) | $5.40 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NEUP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.